Safety of long-term treatment with lurasidone in children and adolescents with bipolar depression: interim analysis of a 2-year extension study

被引：0
|
作者：
DelBello, M. P. [1 ]
Goldman, R. [2 ]
Tocco, M. [2 ]
Pikalov, A. [2 ]
Deng, L. [3 ]
Loebel, A. [4 ,5 ]
机构：
[1] Univ Cincinnati, Coll Med, Dept Psychiat, Div Bipolar Disorders Res, Cincinnati, OH 45221 USA
[2] Sunov Pharmaceut Inc, Med Affairs, Marlborough, MA USA
[3] Sunov Pharmaceut Inc, Biostat, Ft Lee, NJ USA
[4] Sunov Pharmaceut Inc, Med Affairs, Ft Lee, NJ USA
[5] Paladin Consulting Grp, Psychiat, Princeton, NJ USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2019年 / 29卷
关键词：
D O I：
10.1016/j.euroneuro.2018.11.565
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.550
引用
收藏
页码：S368 / S369
页数：2
相关论文
共 50 条
  • [21] Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study
    Ishigooka, Jun
    Kato, Tadafumi
    Miyajima, Mari
    Watabe, Kei
    Masuda, Takahiro
    Hagi, Katsuhiko
    Higuchi, Teruhiko
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2021, 281 : 160 - 167
  • [22] Effect of lurasidone on cognition in adolescents with schizophrenia: A one-year interim analysis of a 2-year open-label extension study
    Harvey, P. D.
    Goldman, R.
    Tocco, M.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    [J]. EUROPEAN PSYCHIATRY, 2018, 48 : S123 - S123
  • [23] Long-term safety and efficacy of risperidone in children with disruptive behaviour disordersResults of a 2-year extension study
    Magali Reyes
    Roza Olah
    Krisztina Csaba
    Ilse Augustyns
    Marielle Eerdekens
    [J]. European Child & Adolescent Psychiatry, 2006, 15 : 97 - 104
  • [24] Safety and effectiveness of lurasidone in adolescents with schizophrenia: results of a 2-year, open-label extension study
    Correll, Christoph U.
    Findling, Robert L.
    Tocco, Michael
    Pikalov, Andrei
    Deng, Ling
    Goldman, Robert
    [J]. CNS SPECTRUMS, 2022, 27 (01) : 118 - 128
  • [25] Efficacy and safety of lurasidone in adolescents with schizophrenia: Results of a 2-year, open-label extension study
    Goldman, R.
    Correll, C.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S88 - S89
  • [26] Long-term safety and efficacy of risperidone in children with disruptive behaviour disorders - Results of a 2-year extension study
    Reyes, M
    Olah, R
    Csaba, K
    Augustyns, I
    Eerdekens, M
    [J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2006, 15 (02) : 97 - 104
  • [27] Tolerability, Safety, and Effectiveness of Two Years of Treatment with Lurasidone in Children and Adolescents with Bipolar Depression
    DelBello, Melissa P.
    Tocco, Michael
    Pikalov, Andrei
    Deng, Ling
    Goldman, Robert
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2021, 31 (07) : 494 - 503
  • [28] EFFECT OF LURASIDONE ON COGNITIVE FUNCTION IN PEDIATRIC BIPOLAR DEPRESSION: RESULTS OF A 2-YEAR OPEN-LABEL EXTENSION STUDY
    Burdick, Katherine
    Tocco, Michael
    Pikalov, Andrei A.
    Deng, Ling
    Goldman, Robert S.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (10): : S248 - S248
  • [29] Effect of lurasidone on cognition in adolescents with schizophrenia: analysis of a 2-year open-label extension study
    Harvey, P. D.
    Goldman, R.
    Tocco, M.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    [J]. EUROPEAN PSYCHIATRY, 2019, 56 : S284 - S285
  • [30] Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
    Santos, Raul D.
    Duell, P. Barton
    East, Cara
    Guyton, John R.
    Moriarty, Patrick M.
    Chin, Wai
    Mittleman, Robert S.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 (09) : 566 - 575
12345